Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ClearMetrX is a healthcare analytics and reporting software company focused on physicians, management services organizations, 340B covered entities, and pharmacies. The company offers a cloud-based, end-to-end platform that helps healthcare organizations manage operational, pharmacy, and drug-pricing data, including through products such as 340MetrX. ClearMetrX positions its software as a decision-support and reporting system intended to improve efficiency, inventory management, patient adherence, compliance, and profitability. It operates as a subsidiary of NextPlat and appears to be commercially active, with an AI-enhanced ClearMetrX 4.0 product announced for commercialization in the first half of 2026. The business is healthcare-related, but it is not a biotech or therapeutics developer and does not have a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ClearMetrX.